Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Firth

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 16, 2005
A randomized controlled trial of late conversion from CNI-based to sirolimus-based immunosuppression following renal transplantationChristopher J E Watson, John Firth, Paul F Williams, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 13, 2005
Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five yearsChristopher J E Watson, J Andrew Bradley, Peter J Friend, et al.
BMJ (Clinical Research Ed.)|November 26, 2014
Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient dataGreg A Knoll, Madzouka B Kokolo, Ranjeeta Mallick, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 16, 2005
A randomized controlled trial of late conversion from CNI-based to sirolimus-based immunosuppression following renal transplantationChristopher J E Watson, John Firth, Paul F Williams, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 13, 2005
Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five yearsChristopher J E Watson, J Andrew Bradley, Peter J Friend, et al.
BMJ (Clinical Research Ed.)|November 26, 2014
Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient dataGreg A Knoll, Madzouka B Kokolo, Ranjeeta Mallick, et al.
Pageof 3